Lv1
30 积分 2021-10-15 加入
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
5天前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia
1个月前
已完结
Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance
5个月前
已完结
Combining electrocardiographic and echocardiographic indexes to detect cardiac amyloidosis: A step forward in the quest to diagnose cardiac amyloidosis without delay
5个月前
已完结
Comparative analysis of electrocardiographic patterns of ventricular hypertrophy in cardiac amyloidosis and other cardiomyopathies
5个月前
已完结
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
6个月前
已完结
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction
6个月前
已完结
Long‐term efficacy of tafamidis in patients with transthyretin amyloid cardiomyopathy by National Amyloidosis Centre stage
6个月前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
6个月前
已完结
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
6个月前
已完结
皖公网安备34019202002308
